TokenPost topic
2 TokenPost stories are tagged Epcoritamab. The newest appear first.
Petosemtamab and Rina-S came through acquisitions, while Genmab is developing epcoritamab with AbbVie.
Nov 3, 2026, 7:08 AM EST · Business
Genmab showcased epcoritamab’s expanded potential across lymphomas and unveiled AI-driven R&D initiatives at major oncology conferences to support pipeline growth.
Jun 14, 2026, 10:26 PM EDT · Business